Tada! [Regulatives / Guidelines]

posted by nobody – 2014-11-19 14:55 (4229 d 04:52 ago) – Posting: # 13880
Views: 16,414

Other range of 90%-111% only for narrow therapeutic index drugs in Europe

The truncated AUC concept is clear, but they don't trust a BE trial in healthy adults at the FDA and started a PK-PD study in children, that's the point where I say: The concept of BE is not accepted any more in general.

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
172 visitors (0 registered, 172 guests [including 20 identified bots]).
Forum time: 20:48 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5